<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02858830</url>
  </required_header>
  <id_info>
    <org_study_id>15-009144</org_study_id>
    <nct_id>NCT02858830</nct_id>
  </id_info>
  <brief_title>Familial Partial Lipodystrophy Study</brief_title>
  <acronym>FPL</acronym>
  <official_title>Genetic and Metabolic Basis of Familial Partial Lipodystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studying patients with rare adipose tissue disorders may help the investigators to better
      understand the pathophysiology of diabetes and dyslipidemia in relation to adiposity, and
      thus have an enormous impact on public health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A systematic study of body fat distribution is necessary to better define the phenotypic
      spectrum of FPL, and to better recognize FPL in patients with Metabolic Syndrome. Similarly,
      genetic studies in these patients will not only help better characterize the
      genotype-phenotype relationship, but is also likely to help identify other genes involved in
      regulation of lipid homeostasis, as some patients may not have any of the known mutations.

      The Investigators will systematically study mitochondrial protein quality and function under
      fasting and fed state in relation to intramyocellular and circulating plasma lipid levels,
      and compare with age, sex and BMI-matched individuals. The Investigators will also study the
      rate of de-novo protein synthesis to determine if hyperinsulinemia affects both muscle
      protein anabolism and catabolism.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper body muscle strength measured by chest press dynamometry</measure>
    <time_frame>Before consumption of a high fat mixed meal</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in fractional mitochondrial protein synthesis rates</measure>
    <time_frame>Before and after consumption of a high fat mixed meal (approximately 4 hours after the meal)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Lower body muscle strength measured by knee extension</measure>
    <time_frame>Before consumption of a high fat mixed meal</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Lipodystrophy, Familial Partial</condition>
  <arm_group>
    <arm_group_label>Group 1: Healthy Subject</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy Subject (Control) will undergo assessments before and after ingesting a high fat mixed meal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: FPL Subject</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>FPL Subject will undergo assessments before and after ingesting a high fat mixed meal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High fat mixed meal</intervention_name>
    <arm_group_label>Group 1: Healthy Subject</arm_group_label>
    <arm_group_label>Group 2: FPL Subject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical diagnosis of lipodystrophy (decreased subcutaneous fat)

          2. Family history of lipodystrophy

          3. Normal control subject

        Exclusion Criteria:

          1. Inability to provide informed consent

          2. Hemoglobin &lt; 10g%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vinaya Simha, MBBS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremy M Weiss</last_name>
    <phone>507-266-1944</phone>
    <email>RSTDOMCTU@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samantha McAllister</last_name>
    <phone>507-266-1944</phone>
    <email>RSTDOMCTU@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy M Weiss</last_name>
      <phone>507-266-1944</phone>
      <email>RSTDOMCTU@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Samantha McAllister</last_name>
      <phone>507-266-1944</phone>
      <email>RSTDOMCTU@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vinya Simha, MBBS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Vinaya Simha, M.B.B.S., M.D.</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>FPL</keyword>
  <keyword>adipose tissue</keyword>
  <keyword>diabetes</keyword>
  <keyword>dyslipidemia</keyword>
  <keyword>metabolic</keyword>
  <keyword>hyperinsulinemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy</mesh_term>
    <mesh_term>Lipodystrophy, Familial Partial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

